WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H208069
CAS#: N/A
Description: RvD2n-3 DPA is an endogenously formed mediator biosynthesized from the omega-3 fatty acid n-3 docosapentaenoic acid.
Hodoodo Cat#: H208069
Name: RvD2n-3 DPA
CAS#: N/A
Chemical Formula: C22H34O5
Exact Mass: 378.24
Molecular Weight: 378.510
Elemental Analysis: C, 69.81; H, 9.05; O, 21.13
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: RvD2n-3 DPA; RvD2n-3DPA; RvD2n-3-DPA
IUPAC/Chemical Name: (7S,8E,10Z,12E,14E,16R,17S,19Z)-7,16,17-trihydroxydocosa-8,10,12,14,19-pentaenoic acid
InChi Key: LDVCZYSUILUYKN-BGERNTNVSA-N
InChi Code: InChI=1S/C22H34O5/c1-2-3-9-16-20(24)21(25)17-12-7-5-4-6-10-14-19(23)15-11-8-13-18-22(26)27/h3-7,9-10,12,14,17,19-21,23-25H,2,8,11,13,15-16,18H2,1H3,(H,26,27)/b6-4-,7-5+,9-3-,14-10+,17-12+/t19-,20+,21-/m1/s1
SMILES Code: O[C@@H]([C@H](C/C=C\CC)O)/C=C/C=C/C=C\C=C\[C@@H](O)CCCCCC(O)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 378.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Reinertsen AF, Primdahl KG, De Matteis R, Dalli J, Hansen TV. Stereoselective Synthesis, Configurational Assignment and Biological Evaluations of the Lipid Mediator RvD2n-3 DPA. Chemistry. 2022 Feb 1;28(7):e202103857. doi: 10.1002/chem.202103857. Epub 2021 Dec 28. PMID: 34890076.